The Centre for Research into Injecting Drug Use in Australia have put together an overview of the current naloxone landscape there that is broken down by state.

Bristol Drugs Project have produced three short interviews detailing the experience three different people have had with Naloxone. In this interview, they speak to Lee. He describes his own experience of an opioid overdose and how Naloxone was administered to him saving his life. This is Lee’s Story.

Bristol Drugs Project have produced three short interviews detailing the experience three different people have had with Naloxone. In this interview, they speak to Rebecca who, after getting Naloxone training with BDP, went on to administer Naloxone to a member of the public who was going through an opioid overdose. This is Rebecca’s story.

Bristol Drugs Project have produced three short interviews detailing the experience three different people have had with Naloxone. In this interview they speak to Rich. he describes his experience administering Naloxone to his friend who was going through an opioid overdose. This is Rich’s Story.

The EMCDDA has launched a new online knowledge questionnaire on overdose and take-home naloxone aimed at potential bystanders of overdose, but also at a wider interested public. The main aim of the questionnaire is to refresh respondents’ knowledge on opioids, overdose risks and the role of take-home naloxone as part of the overall response to overdose deaths.

Many people overdose in the presence of their partners or peers. Empowering friends, family and other bystanders to act effectively, before emergency services arrive at the scene, can therefore save lives. Overdose prevention programmes, combining first aid training with the provision of the overdose-reversal drug naloxone, were piloted in Europe in the late 1990s. Now available at local or national level in 12 European countries, these take-home naloxone (THN) programmes are targeted at-risk opioid users and those likely to witness an overdose.